AU6581294A - Ethanolamine derivatives useful for the treatment of gastrointestinal disorders - Google Patents
Ethanolamine derivatives useful for the treatment of gastrointestinal disordersInfo
- Publication number
- AU6581294A AU6581294A AU65812/94A AU6581294A AU6581294A AU 6581294 A AU6581294 A AU 6581294A AU 65812/94 A AU65812/94 A AU 65812/94A AU 6581294 A AU6581294 A AU 6581294A AU 6581294 A AU6581294 A AU 6581294A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- gastrointestinal disorders
- derivatives useful
- ethanolamine derivatives
- ethanolamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 150000002169 ethanolamines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308618A GB9308618D0 (en) | 1993-04-26 | 1993-04-26 | Ethanolamine derivatives |
| GB9308618 | 1993-04-26 | ||
| GB9322238 | 1993-10-28 | ||
| GB939322238A GB9322238D0 (en) | 1993-10-28 | 1993-10-28 | Enthanolamine derivatives |
| PCT/JP1994/000671 WO1994025427A1 (en) | 1993-04-26 | 1994-04-22 | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6581294A true AU6581294A (en) | 1994-11-21 |
Family
ID=26302812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU65812/94A Abandoned AU6581294A (en) | 1993-04-26 | 1994-04-22 | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPH08509491A (en) |
| AU (1) | AU6581294A (en) |
| HU (1) | HUT69285A (en) |
| WO (1) | WO1994025427A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977124A (en) * | 1995-05-10 | 1999-11-02 | Pfizer Inc. | β-adrenergic agonists |
| AUPQ407699A0 (en) * | 1999-11-16 | 1999-12-09 | Fujisawa Pharmaceutical Co., Ltd. | Aminoalcohol derivatives |
| US20040072868A1 (en) * | 2000-09-18 | 2004-04-15 | Collins Jon Loren | Substitued aminopropoxyaryl derivatives useful as agonists for lxr |
| JP3815496B2 (en) | 2002-11-07 | 2006-08-30 | アステラス製薬株式会社 | Overactive bladder therapeutic agent containing an anilide acetate derivative as an active ingredient |
| EP1682494A4 (en) * | 2003-10-30 | 2006-11-08 | Merck & Co Inc | ARALKYLAMINES AS MODULATORS OF CANNABINOID RECEPTORS |
| ES2847239T3 (en) * | 2016-07-07 | 2021-08-02 | Dow Agrosciences Llc | Procedures for the preparation of 4-alkoxy-3- (acyl or alkyl) oxypicolinamides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE1994T1 (en) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | AETHANAMINE DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS. |
| DE3368258D1 (en) * | 1982-07-16 | 1987-01-22 | Beecham Group Plc | 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them |
| GB8415377D0 (en) * | 1984-06-15 | 1984-07-18 | Beecham Group Plc | Compounds |
| GB8620951D0 (en) * | 1986-08-29 | 1986-10-08 | Beecham Group Plc | Compounds |
-
1994
- 1994-04-22 WO PCT/JP1994/000671 patent/WO1994025427A1/en not_active Ceased
- 1994-04-22 HU HU9402835A patent/HUT69285A/en unknown
- 1994-04-22 JP JP6524095A patent/JPH08509491A/en active Pending
- 1994-04-22 AU AU65812/94A patent/AU6581294A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08509491A (en) | 1996-10-08 |
| WO1994025427A1 (en) | 1994-11-10 |
| HUT69285A (en) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
| AU7545594A (en) | Implantable device for the treatment of aedemas | |
| AU6112896A (en) | Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders | |
| AU2053597A (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| AU5860396A (en) | Substituted oxazoles for the treatment of inflammation | |
| AU7931194A (en) | Apparatus for treatment of the oral cavity | |
| AU4494896A (en) | Device for stabilizing jounts of the limbs | |
| AU2103295A (en) | Methods for the treatment of thrombosis | |
| AU2388895A (en) | Substituted cyclopentadienyl compounds for the treatment of inflammation | |
| AU6793594A (en) | Apparatus for the treatment of overbite | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AU1430492A (en) | Pharmaceutical composition for the treatment of gastritis | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
| AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
| AU3187595A (en) | Compounds for the treatment of restenosis | |
| AU1697197A (en) | Immunoconjugate for the treatment of aids | |
| AU2557895A (en) | Composition for treating gastrointestinal disorders | |
| AUPM456894A0 (en) | Treatment for gastric disorders | |
| AU1450392A (en) | Small peptidic compounds useful for the treatment of glaucoma | |
| AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
| AU7812794A (en) | Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract | |
| AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
| AU5526196A (en) | Compositions for the treatment of dandruff |